Martin L. Ogletree

5.2k citations

124 papers · 4.3k indexed · h-index 37

Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 13
Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 20
Internal Medicine top 2%
Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 15
Pharmacology top 1%
- Inflammatory mediators and NSAID effects 27
Physiology
- Nitric Oxide and Endothelin Effects 19
Pathology and Forensic Medicine
- Cardiac Ischemia and Reperfusion 19
Cardiology and Cardiovascular Medicine
- Antiplatelet Therapy and Cardiovascular Diseases 16
Immunology
- Immune Response and Inflammation 13

Co-authors: Kenneth L. Brigham William A. Schumacher Allan M. Lefer James R. Snapper Don N. Harris J. Bryan Smith Alastair A. Hutchison Martin F. Haslanger
Cited by: Biochemistry Hematology Internal Medicine
Journals: Journal of Pharmacology and Experimental Therapeutics (11 papers)Bioorganic & Medicinal Chemistry Letters (9 papers)Prostaglandins (8 papers)
Partner nations: United States Germany Sweden

In The Last Decade

Martin L. Ogletree

121 papers receiving 4.1k citations

Peers

Countries citing papers authored by Martin L. Ogletree

Since Specialization

Citations

This map shows the geographic impact of Martin L. Ogletree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin L. Ogletree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin L. Ogletree more than expected).

Fields of papers citing papers by Martin L. Ogletree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin L. Ogletree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin L. Ogletree. The network helps show where Martin L. Ogletree may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Martin L. Ogletree, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin L. Ogletree Line = papers co-authored together Martin L. Ogletree links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease Thrombosis Research ·Eitan Friedman,Martin L. Ogletree,Elias V. Haddad,Olivier Boutaud	2015	36
2	Inhibiting the intrinsic pathway of coagulation with a factor XII–targeting RNA aptamer Journal of Thrombosis and Haemostasis ·Kathy L. Lawhorn,Yiming Xu,Juliana M. Layzer,Wei Wu,Martin L. Ogletree,Bruce A. Sullenger	2013	78
3	Spontaneous Atherothrombosis and Medial Degradation in Apoe ^−/− , Npc1 ^−/− Mice Circulation ·Carrie L. Welch,Yu Sun,Brian J. Arey,Vincent Lemaître,Naresh Kumar Sharma,Minako Ishibashi,Scott Sayers,Rong Li,Anna Gorelik,Р.А. Амплеев,Peter Talloen,Yoshiyuki Yasuda,Dieter Brömme,Jeanine D’Armiento,Martin L. Ogletree,Alan R. Tall	2007	31
4	Biomarker Optimization to Track the Antithrombotic and Hemostatic Effects of Clopidogrel in Rats Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Jeffrey S. Bostwick,Martin L. Ogletree,Farid Yousef,Thomas E. Steinbacher,Ji Hua,Laura A. Price,Pancras C. Wong,Robert Rehfuss	2007	29
5	Abstract 631: Nonpeptide Factor XIa (FXIa) Inhibitor. In vitro Kinetic Evaluation and in vivo Studies of BMS-262084 on Arterial Thrombosis and Hemostasis in Rabbits Circulation ·Pancras C. Wong,William A. Schumacher,Carol A. Watson,Earl J. Crain,Martin L. Ogletree,Alan R. Rendina	2006	3
6	Effects of factor XI deficiency on ferric chloride‐induced vena cava thrombosis in mice Journal of Thrombosis and Haemostasis ·Xianyu Wang,Patricia L. Smith,M‐Y. HSU,David Gailani,William A. Schumacher,Martin L. Ogletree,Dietmar Seiffert	2006	112
7	Murine model of ferric chloride‐induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor Journal of Thrombosis and Haemostasis ·James Puccinelli,Patricia L. Smith,Mei-Yin Hsu,Martin L. Ogletree,William A. Schumacher	2006	77
8	Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice Journal of Thrombosis and Haemostasis ·Xianyu Wang,Qi Cheng,一秀池野,G Feuerstein,M‐Y. HSU,Patricia L. Smith,Dietmar Seiffert,William A. Schumacher,Martin L. Ogletree,David Gailani	2005	233
9	Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats Molecular Pharmacology ·Xinkang Wang,Giora Feuerstein,Lin Xu,Hugh Wang,William A. Schumacher,Martin L. Ogletree,Rebecca Taub,James J.‐W. Duan,Carl P. Decicco,Rui‐Qin Liu	2004	70
10	Synthesis of potent and highly selective inhibitors of human tryptase Bioorganic & Medicinal Chemistry Letters ·William A. Slusarchyk,Б. Е. Прохоров,Karen S. Hartl,Ming‐Hsing Huang,G. A. JACOBS,Wei Meng,Martin L. Ogletree,Zulan Pi,William A. Schumacher,Steven M. Seiler,James Sutton,Т. К. Томчук,Robert Zahler,Guohua Zhao,Gregory S. Bisacchi	2002	41
11	Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664 Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,S. David Kimball,Steven E. Hall,Soo-Yeon Ko,Edwin J. Iwanowicz,James C. Lin,Robert V. Moquin,曹渊 Yuan CAO,John S. Sack,Mary F. Malley,ChiehYing Y. Chang,Saeho Chong,David Wang‐Iverson,Daniel G. Roberts,Steven M. Seiler,William A. Schumacher,Martin L. Ogletree	2002	10
12	Myocardial Salvage Efficacy of the Thromboxane Receptor Antagonist Ifetroban in Ferrets and Dogs Journal of Cardiovascular Pharmacology ·Allen W. Gomoll,Gary J. Grover,Martin L. Ogletree	1994	8
13	Attenuation of the pulmonary vascular response to endotoxin by a thromboxane synthesis inhibitor (UK-38485) in unanesthetized sheep Journal of Surgical Research ·Milica Savić,Martin L. Ogletree,Kenneth L. Brigham,John W. Hammon	1991	10
14	7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza .omega.-chain analogs Journal of Medicinal Chemistry ·Neslihan Gezer,曹渊 Yuan CAO,Saleh Hasanzadeh,Jagabandhu Das,حسن زندیه,Martin F. Haslanger,W. Czerwinski,Don N. Harris,Anders Hedberg,Martin L. Ogletree,Steven E. Hall	1990	17
15	Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets. Journal of Pharmacology and Experimental Therapeutics ·Anders Hedberg,Edeane Karoline Moreira Gomes,Martin L. Ogletree,Don N. Harris,禹湘 Yu Xiang	1988	78
16	Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey. Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Harold Goldenberg,Don N. Harris,Martin L. Ogletree	1987	10
17	Influence of Steroidal and Nonsteroidal Anti-Inflammatory Agents on the Accumulation of Arachidonic Acid Metabolites in Plasma and Lung Lymph after Endotoxemia in Awake Sheep American Review of Respiratory Disease ·Martin L. Ogletree,Arnold L. Farr,Gayle King,Kenneth L. Brigham	1986	61
18	Modification of pulmonary responses to endotoxemia in awake sheep by steroidal and nonsteroidal anti-inflammatory agents. PubMed ·Arnold L. Farr,Martin L. Ogletree,Barbara Meyrick,Kenneth L. Brigham	1984	32
19	Role of chest wall mechanoreceptors in inhibition of inspiration during mechanical ventilation in humans American Review of Respiratory Disease ·James R. Snapper,Martin L. Ogletree,Alastair A. Hutchison,Kenneth L. Brigham	1981	6
20	Early prostaglandin release from the ischemic myocardium in the dog. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Martin L. Ogletree,金尉武,Mario Feola,Lefer Am	1977	15

About Martin L. Ogletree

Martin L. Ogletree is a scholar working on Internal Medicine, Hematology and Biochemistry, having authored 124 papers that have together received 4.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (27 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers), Nitric Oxide and Endothelin Effects (19 papers), Cardiac Ischemia and Reperfusion (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Eicosanoids and Hypertension Pharmacology (13 papers) and Immune Response and Inflammation (13 papers). The work is most often cited by research in Biochemistry (626 citations), Hematology (635 citations) and Internal Medicine (198 citations). Martin L. Ogletree has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Kenneth L. Brigham, William A. Schumacher, Allan M. Lefer, James R. Snapper, Don N. Harris, J. Bryan Smith, Alastair A. Hutchison, Martin F. Haslanger, K. C. Nicolaou and Masaki Nakane. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Bioorganic & Medicinal Chemistry Letters, Prostaglandins, Journal of Applied Physiology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact